IDH1 and central nervous system cancer: A recent study by Barritault et al. detected IDH1 and TERT promoter mutations from non-diagnostic biopsies from glioma patients using SNaPshot polymerase chain reaction [13], suggesting that methods that are more sensitive than Sanger sequencing may detect mutations in tissues with a low tumor volume.